Buy or sell DaVita stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

DaVita Stock

A leading provider of kidney care.

About DaVita Stock

DaVita a FORTUNE 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2012, DaVita operated or provided administrative services at 1,884 outpatient dialysis centers located in the United States, serving approximately 149,000 patients. The company also operated 19 outpatient dialysis centers located in four countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.

Management

Senior Application Developer

Benjamin Snider

Interim Chief Financial Officer & Chief Accounting Officer

James Hilger

Chairman and CEO

Kent Thiry

IT Director

Jason Richling

Chief Compliance Officer

Jeanine Jiganti

Director, Strategy and Special Projects

Brannan Schell

Vice President of Clinical Affairs

John Wigneswaran

Chief Operating Officer

Joseph Mello

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from DaVita or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo